Buy 5-EAPB chemical drug online
5-EAPB powder (1-(benzofuran-5-yl)-N-ethylpropan-2-amine) is an entactogenic amphetamine which is structurally related to 5-MAPB and 5-APB. It might be predicted to show similar effects to these drugs in humans, but the pharmacology of 5-EAPB remains unstudied as of 2013.
5-EAPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor as well as a triple monoamine reuptake inhibitors, however 5-EAPB is not listed as an example in this patent, and it is not yet established to what extent the activity of 5-EAPB resembles that of 5-APB.
5-EAPB also referred to as 1-(benzofuran-5-yl)-N-ethylpropan-2-amine is an N-ethyl comparison of 5-APB as well as being structurally related to 5-MAPB. The chemical compound is also known to be an entactogenic amphetamine. With its relationship to the above compounds it is thought be agonists of the 5-HT2C receptor along with being a triple monoamine reuptake inhibitors.
5-EAPB (1-(benzofuran-5-yl)-N-ethylpropan-2-amine) is an entactogenic amphetamine which is structurally related to 5-MAPB and 5-APB. It might be predicted to show similar effects to these drugs in humans, but the pharmacology of 5-EAPB remains unstudied as of 2013.
5-EAPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor as well as a triple monoamine reuptake inhibitors, however 5-EAPB is not listed as an example in this patent, and it is not yet established to what extent the activity of 5-EAPB resembles that of 5-APB.
5-EAPB also referred to as 1-(benzofuran-5-yl)-N-ethylpropan-2-amine is an N-ethyl comparison of 5-APB as well as being structurally related to 5-MAPB. The chemical compound is also known to be an entactogenic amphetamine. With its relationship to the above compounds it is thought be agonists of the 5-HT2C receptor along with being a triple monoamine reuptake inhibitors.
As an N-ethyl derivative of 5-APB, 5-EAPB falls outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013, and remains uncontrolled in the UK as of November 2013.
